A detailed history of Deka Bank Deutsche Girozentrale transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 87,000 shares of ABCL stock, worth $256,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,000
Previous 87,000 -0.0%
Holding current value
$256,650
Previous $249,000 10.04%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$5.72 - $10.65 $572,000 - $1.07 Million
-100,000 Reduced 53.48%
87,000 $865,000
Q1 2022

Apr 28, 2022

SELL
$7.46 - $14.14 $59,680 - $113,120
-8,000 Reduced 4.1%
187,000 $1.82 Million
Q4 2021

Feb 02, 2022

BUY
$12.99 - $17.73 $2.53 Million - $3.46 Million
195,000 New
195,000 $2.65 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.